Last reviewed · How we verify
NCT06571513
Written Exposure Therapy to Improve Recovery Among Sexual Assault Survivors
NA trial testing Written Exposure Therapy in Post-traumatic Stress Disorder in 30 participants. Completed in 7 March 2026.
7 March 2026
Quick facts
| Lead sponsor | University of North Carolina, Chapel Hill |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 30 |
| Start date | 23 September 2024 |
| Primary completion | 7 March 2026 |
| Estimated completion | 7 March 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Written Exposure Therapy
- Unemotional Writing
Conditions studied
- Post-traumatic Stress Disorder — all drugs for Post-traumatic Stress Disorder →
Sponsor
University of North Carolina, Chapel Hill
Who can join
18 and older, female only, with Post-traumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective of this pilot trial is to determine the feasibility and initial efficacy of telehealth-delivered written exposure therapy to reduce the development of posttraumatic stress disorder after sexual assault. This pilot trial will provide the data necessary to design and support a large-scale trial.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06571513
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Written Exposure Therapy
Trials testing the same drug.
- NCT07498257 — Adaptation and Randomized Controlled Trial of Written Exposure Therapy for Adolescents · NA · not yet recruiting
- NCT07108608 — Adaptation of Written Exposure Therapy in Substance Treatment · NA · not yet recruiting
- NCT06771817 — Empowering Perinatal Adolescents Through Writing · NA · recruiting
- NCT05674617 — PTSD Treatment for Veterans With Serious Mental Illness to Improve Functional Outcomes · NA · recruiting
- NCT06296940 — Written Exposure in Substance Treatment · NA · completed
Other recruiting trials for Post-traumatic Stress Disorder
Currently open trials in the same condition.
- NCT06943404 — BXCL501 After Stress to Increase Recovery Success · Phase 2 · recruiting
- NCT06477796 — Improving Sleep in Veterans With the Polytrauma Clinical Triad · NA · recruiting
- NCT06538246 — Adaptive Coping Skills Training to Improve Psychological Distress Among Cardiorespiratory Failure Survivors · NA · recruiting
- NCT06592677 — Early Support After Exposure to Trauma · NA · recruiting
- NCT05927324 — Clinician-Assisted Videofeedback Exposure-Approach Therapy (CAVEAT) Trial · NA · recruiting
Other University of North Carolina, Chapel Hill trials
Trials by the same sponsor.
- NCT06841913 — Woodsmoke Exposure, Influenza Infection, and Nasal Immunity · Phase 4 · suspended
- NCT07383428 — The INICIO-Guatemala Study · NA · not yet recruiting
- NCT07528443 — Ultraprocessed Foods in Colombia · NA · not yet recruiting
- NCT07507370 — CARED : A Novel Rapid Treatment Paradigm for Depression · NA · not yet recruiting
- NCT07534254 — Piloting a Generative Artificial Intelligence Chatbot in a Mobile Weight Loss Program · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06571513 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of North Carolina, Chapel Hill
- Last refreshed: 16 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06571513.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing